Mario Cazzola
Overview
Explore the profile of Mario Cazzola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
753
Citations
26127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matera M, Capristo C, de Novellis V, Cazzola M
Expert Rev Anti Infect Ther
. 2025 Mar;
:1-17.
PMID: 40051224
Introduction: Pertussis, a respiratory disease caused primarily by , is undergoing a resurgence despite decades of high rates of vaccination. The prevention of pertussis in infants presents several challenges, including...
2.
DAntonio S, Pennisi A, Cazzola M
Int J Chron Obstruct Pulmon Dis
. 2025 Mar;
20:479-486.
PMID: 40046825
Introduction: The Italian COPD Patient Association (Associazione Pazienti BPCO) conducted an online survey among its 2814 members with COPD to investigate the reasons for the widespread use of mucolytic therapies...
3.
Gurnari C, Robin M, Ades L, Aljurf M, Almeida A, Duarte F, et al.
Blood
. 2025 Feb;
PMID: 39970324
For patients with myelodysplastic neoplasm/syndrome (MDS), allogeneic hematopoietic cell transplantation (allo-HCT) represents the only potentially curative treatment, capable of eradicating disease-related mutant hematopoietic cells and establishing normal donor hematopoiesis. Biologic-assignment...
4.
Di Buduo C, Careddu F, Metti S, Lunghi M, Diprima S, Camilotto V, et al.
Blood Adv
. 2025 Feb;
PMID: 39951616
The pursuit of ex vivo erythrocyte generation has led to the development of various culture systems that simulate the bone marrow microenvironment. However, these models often fail to fully replicate...
5.
Matera M, Calzetta L, Rinaldi B, de Novellis V, Page C, Barnes P, et al.
Expert Opin Drug Discov
. 2025 Feb;
:1-20.
PMID: 39939153
Introduction: The use of laboratory animals is essential to understand the mechanisms underlying COPD and to discover and evaluate new drugs. However, the complex changes associated with the disease in...
6.
Calzetta L, Pistocchini E, Laitano R, Gholamalishahi S, Cazzola M, Rogliani P
Respir Med
. 2025 Jan;
238:107956.
PMID: 39870144
The increasing global elderly population, projected to reach 20 % of individuals aged 65 and over by 2030, faces significant pulmonary challenges, including chronic obstructive pulmonary disease (COPD). Aging is...
7.
Cazzola M, Calzetta L, Matera M, Rogliani P, Patella V
Respir Med
. 2025 Jan;
238:107957.
PMID: 39848410
The management of patients with overlapping asthma and bronchiectasis requires a tailored approach, starting with a comprehensive assessment of the patient's clinical profile, including the severity of asthma and the...
8.
Malcovati L, Cazzola M
Blood
. 2025 Jan;
PMID: 39786421
The term "unexplained cytopenia" is used to describe a condition characterized by peripheral blood (PB) cytopenia that cannot be attributed to identifiable causes using conventional tests or to any concomitant...
9.
Cazzola M, Rogliani P, Matera M
Lancet Respir Med
. 2024 Dec;
13(1):5-6.
PMID: 39653045
No abstract available.
10.
Cazzola M, Calzetta L, Rogliani P, Matera M
Expert Rev Clin Pharmacol
. 2024 Dec;
17(12):1149-1161.
PMID: 39625645
Introduction: The therapeutic implications of phosphodiesterase (PDE) inhibitors have attracted interest because PDEs are regarded as an intracellular target to be exploited for therapeutic advancements in the treatment of COPD....